Rafael Delgado

About

Rafael Delgado is the Head at Instituto de Investigación Hospital Universitario 12 de Octubre in Spain. His research primarily focuses on immunology, particularly in relation to SARS-CoV-2 infection and vaccination. Recent publications include studies on the CD8+ T-cell response in COVID-19 patients and vaccinees, as well as the implications of immune responses in various patient profiles. Delgado also explores pharmacological agents, such as n?-Phenylacetohydrazide derivatives, for viral entry inhibition.